Equities

Hartalega Holdings Bhd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Hartalega Holdings Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)0.845
  • Today's Change-0.01 / -1.17%
  • Shares traded8.14m
  • 1 Year change-61.06%
  • Beta0.4340
Data delayed at least 15 minutes, as of Mar 03 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hartalega Holdings Berhad is an investment holding company. The Company is engaged in the manufacture and sale of nitrile and latex gloves. Its product categories include market segment, glove type, speciality gloves, and smart packing. Its market segment includes healthcare, dental, life sciences, food, industrial, spa and beauty salon, veterinary, and tattoo. Its glove type includes nitrile, latex, polyisoprene, and polychloroprene. Its speciality gloves include antimicrobial, colloidal oatmeal coated, accelerator free, biodegradable, and polychloroprene glove. Its smart packing includes Goodpac and Goodpac +. Its subsidiaries include Hartalega Sdn. Bhd., Hartalega NGC Sdn. Bhd., Hartalega Research Sdn. Bhd., MUN Global Sdn. Bhd., Hartalega NSM Sdn. Bhd., Hartalega Corporate Services Sdn. Bhd., among others. Hartalega Sdn. Bhd. and Hartalega NGC Sdn. Bhd. is engaged in manufacturing of latex gloves. Hartalega Research Sdn. Bhd. is engaged in research and development.

  • Revenue in MYR (TTM)2.23bn
  • Net income in MYR77.03m
  • Incorporated2006
  • Employees7.56k
  • Location
    Hartalega Holdings BhdC-G-9, 1 Jalan Dataran SDKUALA LUMPUR 52200MalaysiaMYS
  • Phone+60 362771733
  • Fax+60 362802533
  • Websitehttps://hartalega.com.my/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Innovita Biological Technology Co Ltd245.90m76.14m2.79bn547.0036.532.41--11.350.97780.97783.1514.840.19922.2812.73787,869.506.1718.666.5220.9776.4378.3430.9643.4216.16--0.002512.0529.9935.1141.9263.2528.63--
Assure Tech (Hangzhou) Co Ltd264.01m68.97m2.82bn741.0040.880.9571--10.680.95110.95113.6440.620.08092.222.17624,449.302.1123.692.3028.0130.3264.6126.1147.6511.28--0.001218.787.4220.8535.8528.6963.16--
Japan Lifeline Co Ltd1.45bn226.26m2.82bn1.25k12.281.7610.511.94129.28129.28829.90900.800.79181.293.9746,563,200.0012.348.9914.8111.2659.7858.1215.5812.652.09--0.048672.6310.171.8123.983.76-9.0512.82
Pegavision Corp858.96m200.04m2.84bn589.0014.352.049.693.3120.4120.4187.66143.870.45344.157.45--10.7114.5714.1419.6152.7753.4823.6123.861.42--0.112746.950.404215.2310.5530.9522.1434.94
Nanosonics Ltd.577.32m57.27m2.86bn470.0050.984.6835.774.960.06650.06650.67050.72420.77592.274.94440,987.207.706.488.967.5377.1677.939.928.695.77--0.02950.0016.8314.7059.3915.3235.13--
Hartalega Holdings Berhad2.23bn77.03m2.93bn7.56k37.900.665212.221.310.02260.02260.65361.290.4637--6.28295,219.601.5921.581.6924.55--44.863.4328.016.73125.860.002150.3240.67-2.43496.29-29.68-5.16--
BrainAurora Medical Technology Ltd97.63m-120.45m2.95bn174.00--19.42--30.25-0.1895-0.18950.15360.22290.3274--1.241,222,976.00-40.54---112.29--41.26---123.83-----10.130.6324--82.01--44.78------
Jiangsu Bioperfectus Technologies Co Ltd193.44m-14.81m2.96bn592.00--1.75--15.33-0.3096-0.30964.0435.380.09031.856.13572,683.70-0.691920.36-0.79624.5558.2262.71-7.6631.893.22--0.132928.76-13.293.9099.46---9.88--
SWS Hemodialysis Care Co Ltd418.57m64.72m3.02bn1.10k46.753.00--7.210.35380.35382.295.520.35772.806.23665,688.205.235.685.836.5445.7145.7914.6116.065.25--0.001428.46-17.8031.86-63.55--24.70--
Hangzhou Biotest Biotech Co Ltd273.13m58.52m3.02bn603.0050.982.27--11.070.69640.69643.0615.660.19133.205.70793,854.104.0223.634.2526.2050.5756.5921.0041.4713.08--0.0000834.4226.5321.7859.0143.1244.08--
Yidu Tech Inc425.87m-50.94m3.03bn823.00--1.39--7.12-0.096-0.0960.80194.150.159524.781.341,030,659.00-2.03-24.00-2.38-30.0834.4135.64-12.72-123.004.37--0.0321---11.415.0839.58--26.45--
Qingdao NovelBeam Technology Co Ltd326.25m99.47m3.06bn841.0030.784.06--9.371.451.454.7610.990.38170.99325.67679,901.1011.3912.7012.6114.1164.3463.1529.8433.963.4351.040.105840.95-5.9011.86-7.1113.4813.44--
Data as of Mar 03 2026. Currency figures normalised to Hartalega Holdings Bhd's reporting currency: Malaysian Ringgit MYR

Institutional shareholders

13.58%Per cent of shares held by top holders
HolderShares% Held
Kumpulan Wang Persaraanas of 10 Feb 2026210.58m6.14%
AIA Bhd.as of 25 Jun 202570.82m2.07%
The Vanguard Group, Inc.as of 04 Feb 202657.33m1.67%
Eastspring Investments Bhd.as of 30 Jun 202532.58m0.95%
BlackRock Fund Advisorsas of 06 Feb 202620.46m0.60%
Dimensional Fund Advisors LPas of 05 Feb 202618.04m0.53%
ATRAM Trust Corp.as of 31 Dec 202415.36m0.45%
Norges Bank Investment Managementas of 30 Jun 202513.64m0.40%
Principal Asset Management Bhd.as of 31 Dec 202513.38m0.39%
Lembaga Tabung Hajias of 25 Jun 202513.30m0.39%
More ▼
Data from 31 Dec 2024 - 26 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.